Investing Profile

Wende Hutton

VCInvestor

General Partner at Canaan Partners

canaan.com/team/wende-huttonMenlo Park, California
Photo of Wende Hutton, General Partner at Canaan Partners

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Canaan Partners General Partner
$250K - $20.0M
$10.0M
44
$800M
CompanyStageDateRound SizeTotal Raised
OncoResponse
Series CMar 2021$40.6M
Series AMay 2016$12.5M
$53.1M
Hyalex Orthopaedics
Series AMar 2019$17M
Series AMay 2017$16M
$33M
Co-investors: Bill Harrington (Osage University Partners), Renee Compton Ryan (Johnson & Johnson Innovation)
Glooko
Series CJun 2017$35M
Series CSep 2016$8M
Series BMar 2015$16.5M
$71M
Co-investors: Chamath Palihapitiya (Social Capital), David Carrico (Jlabs), Venky Harinarayan (rocketship.vc), Ted Maidenberg (Tribe Capital), Sundeep Madra, Bill Campbell
Antiva Biosciences
Series CMar 2017$22M
Series BAug 2015$16M
$38M
ReVision Optics
Venture RoundNov 2016$32M
Series EJul 2013$55M
Series EApr 2013$15M
Series DJul 2010$35M
$137M
Co-investors: Gil Kliman (InterWest), Reza Zadno (InterWest), Renee Compton Ryan (Johnson & Johnson Innovation)
Chrono Therapeutics
Series BSep 2016$47.6M
Series AJun 2014$32M
$79.6M
Co-investors: Liz Rockett (Kaiser Permanente Ventures), James Young (5am Ventures), Cameron McLain (Giant Ventures)
ALDEA Pharmaceuticals
Series BAug 2014$24M
Venture RoundApr 2013$2M
$26M
Dermira
Series CAug 2014$51M
Series BJun 2013$35M
Series AOct 2011$42M
$128M
Co-investors: Jake Nunn (New Enterprise Associates (NEA))